LOADING
Comparing Eli Lilly and Company (LLY) and Nike Inc (NKE) across the Health Care and Consumer Discretionary sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | LLY | NKE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | -- | $66.3B |
| P/E Ratio | -- | 29.5 |
| Forward P/E | -- | 23.5 |
| PEG Ratio | -- | 1.41 |
| EPS | -- | $1.52 |
| Revenue Growth (YoY) | -- | 0.1% |
| Profit Margin | -- | 4.8% |
| Return on Equity | -- | 16.0% |
| Dividend Yield | -- | 3.55% |
| Beta | -- | 1.32 |
| 52-Week High | -- | $78.71 |
| 52-Week Low | -- | $42.09 |
| Volume | -- | -- |